MA42681B1 - Ezh2 inhibitors - Google Patents
Ezh2 inhibitorsInfo
- Publication number
- MA42681B1 MA42681B1 MA42681A MA42681A MA42681B1 MA 42681 B1 MA42681 B1 MA 42681B1 MA 42681 A MA42681 A MA 42681A MA 42681 A MA42681 A MA 42681A MA 42681 B1 MA42681 B1 MA 42681B1
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- ezh2 inhibitors
- tumors
- ezh2
- enhancer
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés qui inhibent l'activité de l'histone lysine n-méthyltransférase ezh2 (enhancer of zeste homolog 2), des compositions pharmaceutiques comprenant ces composés, et des méthodes d'utilisation de ces composés pour traiter le cancer, par exemple les tumeurs hématologiques et les tumeurs solides.The present invention relates to compounds which inhibit the activity of the histone lysine n-methyltransferase ezh2 (enhancer of zeste homolog 2), pharmaceutical compositions comprising these compounds, and methods of using these compounds to treat cancer, for example example haematological tumors and solid tumors.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15382433 | 2015-08-27 | ||
PCT/US2016/047989 WO2017035060A1 (en) | 2015-08-27 | 2016-08-22 | Inhibitors of ezh2 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42681B1 true MA42681B1 (en) | 2020-01-31 |
Family
ID=54145713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42681A MA42681B1 (en) | 2015-08-27 | 2016-08-22 | Ezh2 inhibitors |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR105666A1 (en) |
MA (1) | MA42681B1 (en) |
-
2016
- 2016-08-10 AR ARP160102455A patent/AR105666A1/en unknown
- 2016-08-22 MA MA42681A patent/MA42681B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR105666A1 (en) | 2017-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020013649A (en) | Compositions and methods for inhibiting arginase activity. | |
MX2017012730A (en) | Inhibitors of indoleamine 2,3-dioxygenase for the treatment of cancer. | |
PH12015502028A1 (en) | Ido inhibitors | |
MX366875B (en) | Ido inhibitors. | |
MX2016002075A (en) | Ido inhibitors. | |
EA201891057A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | |
PH12016502179A1 (en) | Inhibitors of lysine specific demethylase-1 | |
EA201591599A1 (en) | IDO INHIBITORS | |
PH12018500423A1 (en) | Inhibitors of ezh2 | |
MX2015017486A (en) | Ido inhibitors. | |
MX2017015923A (en) | Ido inhibitors. | |
MA47736B1 (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
MA43052B1 (en) | Human Plasma Kallikrein Inhibitors | |
MA42681B1 (en) | Ezh2 inhibitors | |
MA43158B1 (en) | Oxa-diazadispiro compounds with activity against pain | |
EA202190125A1 (en) | PYRIDOPYRIMIDINONE DERIVATIVES FOR USE AS Axl INHIBITORS | |
EA202191138A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | |
EA202191495A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | |
EA201892527A1 (en) | INHIBER INHIBITORS HOMOLOGIST 2 ZESTE PROTEIN |